- US tariff: ‘No major impact on pharma’ The Times of India
- Top Indian drugmakers bank on bilateral talks for relief from planned US tariffs (February 20) Hindustan Times
- Indian drugmakers can retain US dominance even with tariffs, says industry body Reuters
- Trump tariffs on pharma: Natco Pharma is scouting for acquisitions in US, RoW markets BusinessLine
- Bitter pill for Indian pharma as Trump tariffs could hurt exports by $2.25 bn Mint
US tariff: ‘No major impact on pharma’ The Times of IndiaTop Indian drugmakers bank on bilateral talks for relief from planned US tariffs (February 20) Hindustan TimesIndian drugmakers can retain US dominance even with tariffs, says industry body ReutersTrump tariffs on pharma: Natco Pharma is scouting for acquisitions in US, RoW markets BusinessLineBitter pill for Indian pharma as Trump tariffs could hurt exports by $2.25 bn Mint Top stories – Google News